Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vuk Gordić

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|November 13, 2025
Novel Ruthenacarborane-NSAID ConjugatesSonam Sonam, Marija Mojić, Vuk Gordić, et al.
Chemmedchem|March 18, 2025
Advances in Diclofenac Derivatives: Exploring Carborane-Substituted N-Methyl and Nitrile Analogs for Anticancer TherapyChristoph Selg, Robert Schuster, Aleksandr Kazimir, et al.
Scientific Reports|December 16, 2024
Re-design and evaluation of diclofenac-based carborane-substituted prodrugs and their anti-cancer potentialChristoph Selg, Vuk Gordić, Tamara Krajnović, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|November 13, 2025
Novel Ruthenacarborane-NSAID ConjugatesSonam Sonam, Marija Mojić, Vuk Gordić, et al.
Chemmedchem|March 18, 2025
Advances in Diclofenac Derivatives: Exploring Carborane-Substituted N-Methyl and Nitrile Analogs for Anticancer TherapyChristoph Selg, Robert Schuster, Aleksandr Kazimir, et al.
Scientific Reports|December 16, 2024
Re-design and evaluation of diclofenac-based carborane-substituted prodrugs and their anti-cancer potentialChristoph Selg, Vuk Gordić, Tamara Krajnović, et al.
Pageof 1